GenSight Biologics SA's total assets for Q2 2025 were €7.35M, a decrease of -31.66% from the previous quarter. FR:SIGHT total liabilities were €39.46M for the fiscal quarter, a 4.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.